How Platelets Break Down the Endocannabinoid 2-AG
Two enzymes, MAGL and FAAH, both contributed to the breakdown of 2-AG in platelets, with MAGL characterized in platelets for the first time.
Quick Facts
What This Study Found
Researchers investigated how platelets (blood cells involved in clotting) break down 2-arachidonoylglycerol (2-AG), an endocannabinoid signaling molecule.
They found that both MAGL (monoacylglycerol lipase) and FAAH (fatty acid amide hydrolase) contributed to 2-AG breakdown in rabbit platelets. When FAAH was blocked with specific inhibitors, 2-OG (a related compound) hydrolysis decreased by up to 55%, confirming FAAH involvement.
MAGL was characterized for the first time in platelets, showing Michaelis-Menten kinetics with specific parameters. The enzyme was present in both the cytosolic and membrane fractions of platelets.
Human platelets showed higher 2-acylglycerol hydrolysis rates and different sensitivity to inhibitors compared to rabbit platelets. Immunoblot analysis confirmed MAGL protein (approximately 33 kDa) in both species.
Key Numbers
MAGL Km = 0.11 microM, Vmax = 1.32 nmol/min per mg protein. FAAH inhibitor URB597 IC50 = 129.8 nM. AM374 IC50 = 20.9 nM. FAAH inhibition reduced 2-OG hydrolysis up to 55%. MAGL molecular mass approximately 33 kDa.
How They Did This
Biochemical study using rabbit and human platelets. Radiolabeled 2-AG and 2-OG were used to measure hydrolysis rates. FAAH inhibitors (URB597 and AM374) were used to separate MAGL and FAAH contributions. Subcellular fractionation, kinetic characterization, and immunoblot analysis were performed.
Why This Research Matters
Understanding how endocannabinoids are broken down in blood cells is important for developing drugs that target the endocannabinoid system. Platelets are accessible blood cells that could serve as biomarkers for endocannabinoid system function.
The Bigger Picture
The endocannabinoid system involves a complex balance of synthesis and degradation. Understanding all the enzymes and cell types involved in endocannabinoid metabolism is essential for developing targeted therapies that modulate the system without unwanted effects.
What This Study Doesn't Tell Us
This was a purely biochemical study in isolated platelets. The physiological significance of platelet endocannabinoid metabolism in whole-blood signaling was not established. Species differences between rabbit and human platelets were noted.
Questions This Raises
- ?What role does platelet endocannabinoid metabolism play in blood clotting and vascular function?
- ?Could platelet MAGL activity serve as a clinical biomarker?
- ?How do platelet endocannabinoid levels change in disease states?
Trust & Context
- Key Stat:
- MAGL characterized in platelets for the first time, with Km of 0.11 microM
- Evidence Grade:
- Basic biochemistry study in isolated platelet preparations from rabbits and humans. Provides mechanistic data, not clinical outcomes.
- Study Age:
- Published in 2009. The understanding of endocannabinoid-metabolizing enzymes has expanded substantially since then.
- Original Title:
- Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase.
- Published In:
- Platelets, 20(6), 376-85 (2009)
- Authors:
- Gkini, Eleni, Anagnostopoulos, Dimitris, Mavri-Vavayianni, Mary, Siafaka-Kapadai, Athanasia
- Database ID:
- RTHC-00357
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is 2-AG and why does it matter?
2-AG (2-arachidonoylglycerol) is one of the two main endocannabinoids, signaling molecules naturally produced in the body that activate cannabinoid receptors. Understanding how it is broken down helps explain how the endocannabinoid system is regulated.
Why study platelets specifically?
Platelets are easily accessible blood cells that produce endocannabinoids in response to stimulation. Understanding endocannabinoid metabolism in platelets could provide insights into vascular and immune signaling and potentially offer a way to monitor endocannabinoid system function clinically.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00357APA
Gkini, Eleni; Anagnostopoulos, Dimitris; Mavri-Vavayianni, Mary; Siafaka-Kapadai, Athanasia. (2009). Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase.. Platelets, 20(6), 376-85.
MLA
Gkini, Eleni, et al. "Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase.." Platelets, 2009.
RethinkTHC
RethinkTHC Research Database. "Metabolism of 2-acylglycerol in rabbit and human platelets. ..." RTHC-00357. Retrieved from https://rethinkthc.com/research/gkini-2009-metabolism-of-2acylglycerol-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.